Table 1.
Activity and Levels of aPKCs and aPKC-dependent Expression of Lipogenic, Proinflammatory and Gluconeogenic Enzymes in Uncultured Hepatocytes of Non-diabetic and Type 2 Diabetic Humans
Parameter | Uncultured Non-Diabetic |
Uncultured T2DM |
P Values |
---|---|---|---|
aPKC Activity | 1 ± 0.14 | 2.53 ± 0.23 | <0.001 |
"PKC-ι mRNA | 1 ± 0.23 | 3.54 ± 0.72 | <0.01 |
"PKC-ι Protein | 1 ± 0.36 | 2.41 ± 0.67 | <0.05 |
SREBP-1c mRNA | 1 ± 0.17 | 3.08 ± 0.70 | <0.05 |
FAS mRNA | 1 ± 0.26 | 3.85 ± 1.15 | <0.05 |
ACC mRNA | 1 ± 0.26 | 2.77 ± 0.61 | <0.05 |
TNFα mRNA | 1 ± 0.26 | 2.55 ± 0.59 | <0.05 |
PEPCK mRNA | 1 ± 0.23 | 2.87 ± 0.61 | <0.05 |
G6Pase mRNA | 1 ± 0.22 | 3.32 ± 0.89 | <0.05 |
PKC-ζ mRNA | 1 ± 0.20 | 0.80 ± 0.19 | NS |
Hepatocytes of 5 non-diabetic and 5 type 2 diabetic (T2DM) subjects were analyzed directly, i.e., without overnight culturing, and results for each patient were expressed relative to the mean value of all non-diabetic patients, set at unity. Values are mean ± SEM of 4–5 determinations. P values were determined ANOVA. NS, not significant